Schiff Nutrition Names Ex-Bayer Exec Shane Durkee as SVP, R&D
Schiff Nutrition International Names SVP, R&D
Schiff Nutrition International, Inc. appointed Shane Durkee to the role of Senior Vice President, Research and Development, effective October 3, 2011. Durkee has more than 16 years of consumer products research and development experience in leading teams in innovation, product development and medical science. Most recently, he was the Director, Global Innovation and New Technology at Bayer Consumer Care AG in Basel, Switzerland. In this position, he led product innovation and development within the Nutritional, Dermatologic and Gastrointestinal business units, which had more than €2 billion in annual sales. He also served in R&D leadership roles working on Bayer’s U.S. branded nutritional business, including One-A-Day, Flintstones and CitraCal. Prior to joining Bayer, Durkee held R&D leadership roles with TwinLab and Nutraceutical Corporation. Durkee holds a B.S. in Microbiology and an M.B.A. He has served as a member of the Senior Scientific Advisory Council for the Council for Responsible Nutrition and as a science advisory board member at Virgo Publishing.
Tarang Amin, president and chief executive officer, Schiff Nutrition Interntaional, stated: “We welcome Shane and believe his proven track record in driving nutritional supplements innovation will contribute significantly to accelerating our new product program and organic growth. Furthermore, his energy, enthusiasm and passion will complement our senior leadership team.”
“I am excited to join Schiff Nutrition and help the company build its strong portfolio of brands,” stated Durkee. “I look forward to working with the management team to help advance the growth strategy of building premium brands, leading innovation, expanding the channel and geographic footprint of the company, pursuing acquisitions, and driving world-class operations.”